ID   TNG2_HUMAN              Reviewed;         276 AA.
AC   Q6ICL3; A8MUE9; B7WNV6; B7Z583; B7Z730; D3DX23; Q8IW05; Q8NAL0; Q8TCS0;
AC   Q96M16;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   28-JUN-2023, entry version 133.
DE   RecName: Full=Transport and Golgi organization protein 2 homolog;
GN   Name=TANGO2; Synonyms=C22orf25;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3; 4; 5 AND 6).
RC   TISSUE=Caudate nucleus, Hippocampus, Mesangial cell, Placenta,
RC   Synovium, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS ASN-125
RP   AND LYS-200.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 53-276 (ISOFORM 1).
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   INVOLVEMENT IN MECRCN, VARIANT MECRCN ARG-154, AND SUBCELLULAR LOCATION.
RX   PubMed=26805781; DOI=10.1016/j.ajhg.2015.12.008;
RA   Lalani S.R., Liu P., Rosenfeld J.A., Watkin L.B., Chiang T., Leduc M.S.,
RA   Zhu W., Ding Y., Pan S., Vetrini F., Miyake C.Y., Shinawi M., Gambin T.,
RA   Eldomery M.K., Akdemir Z.H., Emrick L., Wilnai Y., Schelley S.,
RA   Koenig M.K., Memon N., Farach L.S., Coe B.P., Azamian M., Hernandez P.,
RA   Zapata G., Jhangiani S.N., Muzny D.M., Lotze T., Clark G., Wilfong A.,
RA   Northrup H., Adesina A., Bacino C.A., Scaglia F., Bonnen P.E., Crosson J.,
RA   Duis J., Maegawa G.H., Coman D., Inwood A., McGill J., Boerwinkle E.,
RA   Graham B., Beaudet A., Eng C.M., Hanchard N.A., Xia F., Orange J.S.,
RA   Gibbs R.A., Lupski J.R., Yang Y.;
RT   "Recurrent muscle weakness with rhabdomyolysis, metabolic crises, and
RT   cardiac arrhythmia due to bi-allelic TANGO2 mutations.";
RL   Am. J. Hum. Genet. 98:347-357(2016).
RN   [8]
RP   VARIANT MECRCN 140-ARG--SER-256 DEL.
RX   PubMed=26805782; DOI=10.1016/j.ajhg.2015.12.009;
RA   Kremer L.S., Distelmaier F., Alhaddad B., Hempel M., Iuso A., Kuepper C.,
RA   Muehlhausen C., Kovacs-Nagy R., Satanovskij R., Graf E., Berutti R.,
RA   Eckstein G., Durbin R., Sauer S., Hoffmann G.F., Strom T.M., Santer R.,
RA   Meitinger T., Klopstock T., Prokisch H., Haack T.B.;
RT   "Bi-allelic truncating mutations in TANGO2 cause infancy-onset recurrent
RT   metabolic crises with encephalocardiomyopathy.";
RL   Am. J. Hum. Genet. 98:358-362(2016).
RN   [9]
RP   VARIANTS MECRCN LYS-26; 32-ARG--SER-276 DEL AND CYS-89.
RX   PubMed=30245509; DOI=10.1038/s41436-018-0137-y;
RA   Dines J.N., Golden-Grant K., LaCroix A., Muir A.M., Cintron D.L.,
RA   McWalter K., Cho M.T., Sun A., Merritt J.L., Thies J., Niyazov D.,
RA   Burton B., Kim K., Fleming L., Westman R., Karachunski P., Dalton J.,
RA   Basinger A., Ficicioglu C., Helbig I., Pendziwiat M., Muhle H.,
RA   Helbig K.L., Caliebe A., Santer R., Becker K., Suchy S., Douglas G.,
RA   Millan F., Begtrup A., Monaghan K.G., Mefford H.C.;
RT   "TANGO2: expanding the clinical phenotype and spectrum of pathogenic
RT   variants.";
RL   Genet. Med. 21:601-607(2019).
RN   [10]
RP   ERRATUM OF PUBMED:30245509.
RX   PubMed=30327536; DOI=10.1038/s41436-018-0336-6;
RA   Dines J.N., Golden-Grant K., LaCroix A., Muir A.M., Cintron D.L.,
RA   McWalter K., Cho M.T., Sun A., Merritt J.L., Thies J., Niyazov D.,
RA   Burton B., Kim K., Fleming L., Westman R., Karachunski P., Dalton J.,
RA   Basinger A., Ficicioglu C., Helbig I., Pendziwiat M., Muhle H.,
RA   Helbig K.L., Caliebe A., Santer R., Becker K., Suchy S., Douglas G.,
RA   Millan F., Begtrup A., Monaghan K.G., Mefford H.C.;
RL   Genet. Med. 21:1899-1899(2019).
RN   [11]
RP   VARIANTS MECRCN ARG-20 AND 88-ARG--SER-276 DEL, AND SUBCELLULAR LOCATION.
RX   PubMed=31276219; DOI=10.1002/jimd.12149;
RA   Jennions E., Hedberg-Oldfors C., Berglund A.K., Kollberg G.,
RA   Toernhage C.J., Eklund E.A., Oldfors A., Verloo P., Vanlander A.V.,
RA   De Meirleir L., Seneca S., Sterky F.H., Darin N.;
RT   "TANGO2 deficiency as a cause of neurodevelopmental delay with indirect
RT   effects on mitochondrial energy metabolism.";
RL   J. Inherit. Metab. Dis. 42:898-908(2019).
RN   [12]
RP   VARIANTS MECRCN PHE-5 DEL; PHE-6 DEL; PRO-74 AND 88-ARG--SER-276 DEL.
RX   PubMed=31339582; DOI=10.1002/jimd.12156;
RA   Mingirulli N., Pyle A., Hathazi D., Alston C.L., Kohlschmidt N.,
RA   O'Grady G., Waddell L., Evesson F., Cooper S.B.T., Turner C., Duff J.,
RA   Topf A., Yubero D., Jou C., Nascimento A., Ortez C., Garcia-Cazorla A.,
RA   Gross C., O'Callaghan M., Santra S., Preece M.A., Champion M., Korenev S.,
RA   Chronopoulou E., Anirban M., Pierre G., McArthur D., Thompson K., Navas P.,
RA   Ribes A., Tort F., Schlueter A., Pujol A., Montero R., Sarquella G.,
RA   Lochmueller H., Jimenez-Mallebrera C., Taylor R.W., Artuch R.,
RA   Kirschner J., Gruenert S.C., Roos A., Horvath R.;
RT   "Clinical presentation and proteomic signature of patients with TANGO2
RT   mutations.";
RL   J. Inherit. Metab. Dis. 43:297-308(2020).
RN   [13]
RP   VARIANT MECRCN 233-GLY--SER-276 DEL.
RX   PubMed=33342685; DOI=10.1016/j.arcped.2020.11.004;
RA   Hoebeke C., Cano A., De Lonlay P., Chabrol B.;
RT   "Clinical phenotype associated with TANGO2 gene mutation.";
RL   Arch. Pediatr. 28:80-86(2021).
RN   [14]
RP   VARIANTS MECRCN PRO-20; 32-ARG--SER-276 DEL; 86-ARG--SER-276 DEL;
RP   88-ARG--SER-276 DEL; 182-GLN--SER-276 DEL AND ILE-236.
RX   PubMed=32929747; DOI=10.1002/jimd.12314;
RA   Berat C.M., Montealegre S., Wiedemann A., Nuzum M.L.C., Blondel A.,
RA   Debruge H., Cano A., Chabrol B., Hoebeke C., Polak M., Stoupa A.,
RA   Feillet F., Torre S., Boddaert N., Bruel H., Barth M., Damaj L.,
RA   Abi-Warde M.T., Afenjar A., Benoist J.F., Madrange M., Caccavelli L.,
RA   Renard P., Hubas A., Nusbaum P., Pontoizeau C., Gobin S., van Endert P.,
RA   Ottolenghi C., Maltret A., de Lonlay P.;
RT   "Clinical and biological characterization of 20 patients with TANGO2
RT   deficiency indicates novel triggers of metabolic crises and no primary
RT   energetic defect.";
RL   J. Inherit. Metab. Dis. 44:415-425(2021).
RN   [15]
RP   CHARACTERIZATION OF VARIANT MECRCN 140-ARG--SER-256 DEL, SUBCELLULAR
RP   LOCATION, AND MUTAGENESIS OF 1-MET--TRP-40.
RX   PubMed=32909282; DOI=10.1002/jimd.12312;
RA   Milev M.P., Saint-Dic D., Zardoui K., Klopstock T., Law C., Distelmaier F.,
RA   Sacher M.;
RT   "The phenotype associated with variants in TANGO2 may be explained by a
RT   dual role of the protein in ER-to-Golgi transport and at the
RT   mitochondria.";
RL   J. Inherit. Metab. Dis. 44:426-437(2021).
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:31276219,
CC       ECO:0000269|PubMed:32909282}. Mitochondrion
CC       {ECO:0000269|PubMed:32909282}. Golgi apparatus
CC       {ECO:0000269|PubMed:26805781}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q6ICL3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6ICL3-2; Sequence=VSP_021139;
CC       Name=3;
CC         IsoId=Q6ICL3-3; Sequence=VSP_021137, VSP_021138;
CC       Name=4;
CC         IsoId=Q6ICL3-4; Sequence=VSP_055605;
CC       Name=5;
CC         IsoId=Q6ICL3-5; Sequence=VSP_055604;
CC       Name=6;
CC         IsoId=Q6ICL3-6; Sequence=VSP_055605, VSP_055606, VSP_055607;
CC   -!- DISEASE: Metabolic crises, recurrent, with rhabdomyolysis, cardiac
CC       arrhythmias, and neurodegeneration (MECRCN) [MIM:616878]: An autosomal
CC       recessive disorder characterized by metabolic encephalomyopathic
CC       crises, hypoglycemia, hyperammonemia, episodic rhabdomyolysis,
CC       susceptibility to life-threatening cardiac tachyarrhythmias,
CC       developmental delay, intellectual disability, and mild diffuse cerebral
CC       atrophy. {ECO:0000269|PubMed:26805781, ECO:0000269|PubMed:26805782,
CC       ECO:0000269|PubMed:30245509, ECO:0000269|PubMed:31276219,
CC       ECO:0000269|PubMed:31339582, ECO:0000269|PubMed:32909282,
CC       ECO:0000269|PubMed:32929747, ECO:0000269|PubMed:33342685}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the Tango2 family. {ECO:0000305}.
CC   -!- CAUTION: Has been reported to be located in the Golgi apparatus
CC       (PubMed:26805781). However, another study was unable to detect Golgi
CC       localization (PubMed:32909282). Has also been reported to be located in
CC       the mitochondrion (PubMed:32909282). However, no mitochondrial
CC       localization was detected in another study which reported that the
CC       protein is primarily cytoplasmic (PubMed:31276219).
CC       {ECO:0000269|PubMed:26805781, ECO:0000269|PubMed:31276219,
CC       ECO:0000269|PubMed:32909282}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK057461; BAB71498.1; -; mRNA.
DR   EMBL; AK092484; BAC03902.1; -; mRNA.
DR   EMBL; AK295210; BAH12013.1; -; mRNA.
DR   EMBL; AK298593; BAH12819.1; -; mRNA.
DR   EMBL; AK301366; BAH13466.1; -; mRNA.
DR   EMBL; AK316056; BAH14427.1; -; mRNA.
DR   EMBL; CR456355; CAG30241.1; -; mRNA.
DR   EMBL; AC005663; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006547; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471176; EAX03001.1; -; Genomic_DNA.
DR   EMBL; CH471176; EAX03003.1; -; Genomic_DNA.
DR   EMBL; CH471176; EAX03005.1; -; Genomic_DNA.
DR   EMBL; BC041339; AAH41339.1; -; mRNA.
DR   EMBL; AL713640; CAD28454.1; -; mRNA.
DR   CCDS; CCDS13772.1; -. [Q6ICL3-1]
DR   CCDS; CCDS63404.1; -. [Q6ICL3-2]
DR   CCDS; CCDS63405.1; -. [Q6ICL3-4]
DR   CCDS; CCDS63406.1; -. [Q6ICL3-6]
DR   CCDS; CCDS63407.1; -. [Q6ICL3-5]
DR   RefSeq; NP_001270035.1; NM_001283106.2. [Q6ICL3-1]
DR   RefSeq; NP_001270045.1; NM_001283116.2. [Q6ICL3-1]
DR   RefSeq; NP_001270058.1; NM_001283129.2. [Q6ICL3-4]
DR   RefSeq; NP_001270077.1; NM_001283148.2.
DR   RefSeq; NP_001270083.1; NM_001283154.2.
DR   RefSeq; NP_001270108.1; NM_001283179.2. [Q6ICL3-2]
DR   RefSeq; NP_001270115.1; NM_001283186.2. [Q6ICL3-2]
DR   RefSeq; NP_001270128.1; NM_001283199.2.
DR   RefSeq; NP_001270144.1; NM_001283215.2. [Q6ICL3-6]
DR   RefSeq; NP_001270164.1; NM_001283235.2. [Q6ICL3-5]
DR   RefSeq; NP_001270177.1; NM_001283248.2.
DR   RefSeq; NP_001309072.1; NM_001322143.1. [Q6ICL3-4]
DR   RefSeq; NP_001309077.1; NM_001322148.1.
DR   RefSeq; NP_001309092.1; NM_001322163.1. [Q6ICL3-2]
DR   RefSeq; NP_001309095.1; NM_001322166.1. [Q6ICL3-2]
DR   RefSeq; NP_001309096.1; NM_001322167.1. [Q6ICL3-2]
DR   RefSeq; NP_001309100.1; NM_001322171.1. [Q6ICL3-5]
DR   RefSeq; NP_001309101.1; NM_001322172.1. [Q6ICL3-5]
DR   RefSeq; NP_001309102.1; NM_001322173.1. [Q6ICL3-5]
DR   RefSeq; NP_001309103.1; NM_001322174.1. [Q6ICL3-5]
DR   RefSeq; NP_001309104.1; NM_001322175.1. [Q6ICL3-5]
DR   RefSeq; NP_690870.3; NM_152906.6. [Q6ICL3-1]
DR   RefSeq; XP_011528169.1; XM_011529867.1.
DR   AlphaFoldDB; Q6ICL3; -.
DR   BioGRID; 126178; 28.
DR   IntAct; Q6ICL3; 2.
DR   STRING; 9606.ENSP00000403645; -.
DR   iPTMnet; Q6ICL3; -.
DR   PhosphoSitePlus; Q6ICL3; -.
DR   SwissPalm; Q6ICL3; -.
DR   BioMuta; TANGO2; -.
DR   DMDM; 74709518; -.
DR   EPD; Q6ICL3; -.
DR   jPOST; Q6ICL3; -.
DR   MassIVE; Q6ICL3; -.
DR   MaxQB; Q6ICL3; -.
DR   PaxDb; Q6ICL3; -.
DR   PeptideAtlas; Q6ICL3; -.
DR   ProteomicsDB; 6277; -.
DR   ProteomicsDB; 66397; -. [Q6ICL3-1]
DR   ProteomicsDB; 66398; -. [Q6ICL3-2]
DR   ProteomicsDB; 66399; -. [Q6ICL3-3]
DR   ProteomicsDB; 6827; -.
DR   Antibodypedia; 313; 122 antibodies from 17 providers.
DR   DNASU; 128989; -.
DR   Ensembl; ENST00000327374.9; ENSP00000332721.4; ENSG00000183597.16. [Q6ICL3-1]
DR   Ensembl; ENST00000398042.6; ENSP00000381122.2; ENSG00000183597.16. [Q6ICL3-2]
DR   Ensembl; ENST00000401833.5; ENSP00000384827.1; ENSG00000183597.16. [Q6ICL3-4]
DR   Ensembl; ENST00000401886.5; ENSP00000385662.1; ENSG00000183597.16. [Q6ICL3-2]
DR   Ensembl; ENST00000432883.5; ENSP00000402926.2; ENSG00000183597.16. [Q6ICL3-5]
DR   Ensembl; ENST00000434570.6; ENSP00000391262.2; ENSG00000183597.16. [Q6ICL3-6]
DR   Ensembl; ENST00000456048.5; ENSP00000403645.2; ENSG00000183597.16. [Q6ICL3-4]
DR   GeneID; 128989; -.
DR   KEGG; hsa:128989; -.
DR   MANE-Select; ENST00000327374.9; ENSP00000332721.4; NM_152906.7; NP_690870.3.
DR   UCSC; uc002zrc.3; human. [Q6ICL3-1]
DR   AGR; HGNC:25439; -.
DR   CTD; 128989; -.
DR   DisGeNET; 128989; -.
DR   GeneCards; TANGO2; -.
DR   GeneReviews; TANGO2; -.
DR   HGNC; HGNC:25439; TANGO2.
DR   HPA; ENSG00000183597; Tissue enhanced (heart).
DR   MalaCards; TANGO2; -.
DR   MIM; 616830; gene.
DR   MIM; 616878; phenotype.
DR   neXtProt; NX_Q6ICL3; -.
DR   OpenTargets; ENSG00000183597; -.
DR   Orphanet; 480864; Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome.
DR   PharmGKB; PA143485406; -.
DR   VEuPathDB; HostDB:ENSG00000183597; -.
DR   eggNOG; KOG2342; Eukaryota.
DR   GeneTree; ENSGT00390000012733; -.
DR   HOGENOM; CLU_047037_3_1_1; -.
DR   InParanoid; Q6ICL3; -.
DR   OMA; FAWRPGH; -.
DR   PhylomeDB; Q6ICL3; -.
DR   TreeFam; TF315064; -.
DR   PathwayCommons; Q6ICL3; -.
DR   SignaLink; Q6ICL3; -.
DR   BioGRID-ORCS; 128989; 17 hits in 1153 CRISPR screens.
DR   ChiTaRS; TANGO2; human.
DR   GeneWiki; C22orf25; -.
DR   GenomeRNAi; 128989; -.
DR   Pharos; Q6ICL3; Tbio.
DR   PRO; PR:Q6ICL3; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q6ICL3; protein.
DR   Bgee; ENSG00000183597; Expressed in apex of heart and 147 other tissues.
DR   ExpressionAtlas; Q6ICL3; baseline and differential.
DR   Genevisible; Q6ICL3; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0007030; P:Golgi organization; IBA:GO_Central.
DR   GO; GO:0009306; P:protein secretion; IBA:GO_Central.
DR   InterPro; IPR008551; TANGO2.
DR   PANTHER; PTHR17985; SER/THR-RICH PROTEIN T10 IN DGCR REGION; 1.
DR   PANTHER; PTHR17985:SF8; TRANSPORT AND GOLGI ORGANIZATION PROTEIN 2 HOMOLOG; 1.
DR   Pfam; PF05742; TANGO2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cytoplasm; Disease variant; Golgi apparatus;
KW   Mitochondrion; Neurodegeneration; Reference proteome.
FT   CHAIN           1..276
FT                   /note="Transport and Golgi organization protein 2 homolog"
FT                   /id="PRO_0000253891"
FT   VAR_SEQ         1..126
FT                   /note="MCIIFFKFDPRPVSKNAYRLILAANRDEFYSRPSKLADFWGNNNEILSGLDM
FT                   EEGKEGGTWLGISTRGKLAALTNYLQPQLDWQARGRGELVTHFLTTDVDSLSYLKKVSM
FT                   EGHLYNGFNLIAADL -> MAGHQHTWQAGSTHQLPAAAAGLAGPRA (in isoform
FT                   5)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055604"
FT   VAR_SEQ         1..48
FT                   /note="MCIIFFKFDPRPVSKNAYRLILAANRDEFYSRPSKLADFWGNNNEILS ->
FT                   MPLGAGTPVNVQRREDSATEGSHRLILAANRDEFYSRPSKLADFWGNNNEILS (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_021137"
FT   VAR_SEQ         1..18
FT                   /note="MCIIFFKFDPRPVSKNAY -> MPPKLLCAGRCVGQDGAAQAWHCPPGQGHS
FT                   VWDAVRMPLGAGTPVNVQRREDSATEGSH (in isoform 4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055605"
FT   VAR_SEQ         90..151
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_021139"
FT   VAR_SEQ         151..157
FT                   /note="GTYGLSN -> EPTLSSW (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055606"
FT   VAR_SEQ         158..276
FT                   /note="Missing (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055607"
FT   VAR_SEQ         190..197
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_021138"
FT   VARIANT         5
FT                   /note="Missing (in MECRCN; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:31339582"
FT                   /id="VAR_085626"
FT   VARIANT         6
FT                   /note="Missing (in MECRCN; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:31339582"
FT                   /id="VAR_085627"
FT   VARIANT         20
FT                   /note="L -> P (in MECRCN)"
FT                   /evidence="ECO:0000269|PubMed:32929747"
FT                   /id="VAR_085628"
FT   VARIANT         20
FT                   /note="L -> R (in MECRCN; dbSNP:rs1191958022)"
FT                   /evidence="ECO:0000269|PubMed:31276219"
FT                   /id="VAR_085629"
FT   VARIANT         26
FT                   /note="R -> K (in MECRCN; unknown pathological
FT                   significance; dbSNP:rs1057520382)"
FT                   /evidence="ECO:0000269|PubMed:30245509"
FT                   /id="VAR_085630"
FT   VARIANT         32..276
FT                   /note="Missing (in MECRCN)"
FT                   /evidence="ECO:0000269|PubMed:30245509,
FT                   ECO:0000269|PubMed:32929747"
FT                   /id="VAR_085631"
FT   VARIANT         74
FT                   /note="T -> P (in MECRCN; unknown pathological
FT                   significance; dbSNP:rs1235314092)"
FT                   /evidence="ECO:0000269|PubMed:31339582"
FT                   /id="VAR_085632"
FT   VARIANT         86..276
FT                   /note="Missing (in MECRCN)"
FT                   /evidence="ECO:0000269|PubMed:32929747"
FT                   /id="VAR_085633"
FT   VARIANT         88..276
FT                   /note="Missing (in MECRCN)"
FT                   /evidence="ECO:0000269|PubMed:31276219,
FT                   ECO:0000269|PubMed:31339582, ECO:0000269|PubMed:32909282,
FT                   ECO:0000269|PubMed:32929747"
FT                   /id="VAR_085634"
FT   VARIANT         89
FT                   /note="G -> C (in MECRCN; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30245509"
FT                   /id="VAR_085635"
FT   VARIANT         125
FT                   /note="D -> N (in dbSNP:rs17855650)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_028742"
FT   VARIANT         140..256
FT                   /note="Missing (in MECRCN; delayed ER-to-Golgi transport;
FT                   altered mitochondrial morphology)"
FT                   /evidence="ECO:0000269|PubMed:26805782,
FT                   ECO:0000269|PubMed:32909282"
FT                   /id="VAR_085636"
FT   VARIANT         154
FT                   /note="G -> R (in MECRCN; dbSNP:rs752298579)"
FT                   /evidence="ECO:0000269|PubMed:26805781"
FT                   /id="VAR_076912"
FT   VARIANT         182..276
FT                   /note="Missing (in MECRCN)"
FT                   /evidence="ECO:0000269|PubMed:32929747"
FT                   /id="VAR_085637"
FT   VARIANT         200
FT                   /note="E -> K (in dbSNP:rs17854107)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_028743"
FT   VARIANT         233..276
FT                   /note="Missing (in MECRCN; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:33342685"
FT                   /id="VAR_085638"
FT   VARIANT         236
FT                   /note="T -> I (in MECRCN; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:32929747"
FT                   /id="VAR_085639"
FT   VARIANT         245
FT                   /note="D -> E (in dbSNP:rs16982614)"
FT                   /id="VAR_028744"
FT   MUTAGEN         1..40
FT                   /note="Missing: Abolishes mitochondrial localization."
FT                   /evidence="ECO:0000269|PubMed:32909282"
SQ   SEQUENCE   276 AA;  30937 MW;  99D55353FD1B74E4 CRC64;
     MCIIFFKFDP RPVSKNAYRL ILAANRDEFY SRPSKLADFW GNNNEILSGL DMEEGKEGGT
     WLGISTRGKL AALTNYLQPQ LDWQARGRGE LVTHFLTTDV DSLSYLKKVS MEGHLYNGFN
     LIAADLSTAK GDVICYYGNR GEPDPIVLTP GTYGLSNALL ETPWRKLCFG KQLFLEAVER
     SQALPKDVLI ASLLDVLNNE EAQLPDPAIE DQGGEYVQPM LSKYAAVCVR CPGYGTRTNT
     IILVDADGHV TFTERSMMDK DLSHWETRTY EFTLQS
//
